AI-Powered Weapons Startup Raises $1.5B & Mounjaro Soars Past Wegovy

AI-Powered Weapons Startup Raises $1.5B & Mou...

Up next

American AI Companies Fend Off Chinese Copy Cats & Gen Z Loves Love Island

#884: American AI companies are sounding the alarm on Chinese companies copying their models through “distillation.” Stellantis officially opens its doors to the sale of the tiny car priced at under $15,000. The US is seeing its middle-aged population slowly shrinking and which c ...  Show more

Xbox Hits Reset Button on Business & Netflix Has a ‘Season 2’ Problem

#883: Microsoft cuts over 4,000 jobs including its Xbox unit as it looks to downsize its gaming division. SpaceX joins the Nasdaq in less than a month of it becoming public. Netflix has a retention problem as it struggles to keep viewers hooked onto its shows after its first seas ...  Show more

Recommended Episodes

Pfizer’s Second Gut Punch Shows Pitfalls of Weight-Loss Pills
Bloomberg Businessweek

 Bloomberg News Health Reporter Madison Muller explains how Pfizer’s second weight-loss setback this year is a warning sign that breaking into the lucrative obesity market isn’t going to be easy. Cory Klippsten, CEO at Swan Bitcoin, shares his crypto outlook for 2024. Benjamin Wo ...  Show more

Obesity Drugs Enjoy a Much-Needed Winning Streak
Bloomberg Businessweek

Bloomberg Opinion Pharma Columnist Lisa Jarvis and Bloomberg News Health Reporter Madison Muller discuss a how a clinical trial in obesity drugs is punctuating a string of positive developments that could make the treatments more widely accessible. Kate Hao, Founder and CEO of Ha ...  Show more

Congress in Chaos, The Ozempic Effect, and the Healthcare Strike
Pivot

Kara and Scott discuss declining social media traffic to news sites, Amazon using an algorithm to test how high they could boost prices, and why the boom in weight loss drugs is the “biggest business story of the year.” Also, Kevin McCarthy’s historic ouster marks another predict ...  Show more

Pfizer plays hardball in weight-loss drug fight
FT News Briefing

Palantir lifted its 2025 revenue guidance and Pfizer has filed a second lawsuit against Novo Nordisk and obesity drug start-up Metsera. Plus, OpenAI inked a $38bn computing deal with Amazon, and the FT’s Claire Jones explains how the Trump administration is considering pushing fo ...  Show more